4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001968281-26-000020
Director sold 116 shares at $163.29 ($18,942)
- Director acquired 250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tariq Musa · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +250 | 11,298 | D | ||
| 2026-07-16 | Sale : show line 2 in the form 10b5-1 | −116 | $163.29 | $18,942 | 11,182 | D |
| Open-market sales · 116 sh · avg $163.29 · $18,942 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-15 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −250 | 1,999 | D |
Loading xslF345X06/wk-form4_1784235380.xml…